Dr Jacques Mallet, former SVP of Portfolio Analytics/Corporate Strategy at Sanofi, joins NEUWAY's Advisory Board as independent member adding in depth expertise in pharma corporate development,
Dr Jacques Mallet, former SVP of Portfolio Analytics/Corporate Strategy at Sanofi, joins NEUWAY’s Advisory Board as independent member adding in depth expertise in pharma corporate development, financing and clinical affairsBONN, Germany (BUSINESS WIRE) #biotechnology NEUWAY Pharma GmbH, « NEUWAY », a preclinical.